Mindfulness Intervention for Fibromyalgia Delivered Through a Smartphone App
Key facts
- Who runs it
- Brigham and Women's Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 54 people enrolled
- Started
- 3 May 2024
- Ended
- 1 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Mindfulness Intervention
- Record updated
- 29 January 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Adults aged 18 to 65
- Diagnosis of fibromyalgia per Wolfe et al. (2011) criteria
- Stable medication regimen or medication-free
- Fluent in English
- Able to provide informed consent
Who cannot take part
- Comorbid pain condition more severe than fibromyalgia
- Current psychosis or history of severe psychiatric illness
- Any condition that may interfere with study compliance as judged by the PI or study coordinator
- Pregnancy or breastfeeding
- Active suicidal ideation
- Participation in another therapeutic trial
Where in United States
- The Brigham and Women's Hospital Department of AnesthesiologyBoston, United States
About the trial
What the trial wants to find out
The purpose of this pilot feasibility study is to evaluate the effects of a smartphone-based mindfulness intervention (MBI) on pain-related outcomes in individuals with fibromyalgia. This 8-week randomized controlled trial will compare an MBI app group to a control group who completes assessments only through the app.
Read full original descriptionShow less
The MBI intervention includes weekly video content focused on mindfulness practice and psychoeducation, combined with daily symptom tracking through the app. Participants in both groups will complete self-report measures at baseline, post-intervention, and follow-ups at 3 and 6 months.
The study will enroll up to 100 participants from Brigham and Women's Hospital and the greater Boston area. This pilot study is designed to assess feasibility and explore preliminary effects on outcomes such as pain interference, fibromyalgia symptoms, pain catastrophizing, sleep disturbance, emotional distress, mindfulness, and pain acceptance. Results will be used to inform the design of a future fully powered randomized trial.
The 2 groups in the trial
- Mindfulness-Based Intervention (MBI)Treatment being tested
Participants in this group will receive access to a smartphone app delivering an 8-week mindfulness-based intervention. The app includes weekly video modules (mindfulness practice and psychoeducation), daily pain tracking, and weekly assessments.
Treatment: Mindfulness Intervention
- ControlNo study treatment, for comparison
Participants in this group will complete the same daily and weekly assessments via the smartphone app but will not have access to the mindfulness or psychoeducation content.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 29 January 2026